|
|
Volumn 28, Issue 30, 2010, Pages
|
|
Risk of arterial thrombosis not increased by sorafenib or sunitinib
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
PLACEBO;
SORAFENIB;
SUNITINIB;
ANGIOGENESIS INHIBITOR;
BENZENESULFONIC ACID DERIVATIVE;
INDOLE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
ARTERY THROMBOSIS;
CANCER PATIENT;
COMPUTER ASSISTED TOMOGRAPHY;
HUMAN;
KIDNEY CANCER;
LETTER;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK FACTOR;
CHEMICALLY INDUCED DISORDER;
EVIDENCE BASED MEDICINE;
NOTE;
PERIPHERAL OCCLUSIVE ARTERY DISEASE;
REPRODUCIBILITY;
THROMBOEMBOLISM;
ANGIOGENESIS INHIBITORS;
ARTERIAL OCCLUSIVE DISEASES;
BENZENESULFONATES;
EVIDENCE-BASED MEDICINE;
HUMANS;
INDOLES;
PROTEIN KINASE INHIBITORS;
PYRIDINES;
PYRROLES;
REPRODUCIBILITY OF RESULTS;
RISK ASSESSMENT;
RISK FACTORS;
THROMBOEMBOLISM;
|
|
EID: 78049501837
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2010.31.0219 Document Type: Letter |
|
Times cited : (8)
|
|
References (7)
|
